Digital Diabetes Market Size Share Growth and Forecast 2024-2031

Digital Diabetes Market Size, Share, Industry, Forecast and outlook (2024-2031)

<h2>Global Digital Diabetes Market is segmented By Type (Type 1 Diabetes, Type 2 Diabetes) By Solution (Glucose Monitoring Systems, Insulin Delivery Devices, Diabetes Management Apps, Telemedicine Services, Others) By Technology (IoT and Wearables, Mobile Applications, Web-based Solutions, Artificial Intelligence (AI) and Machine Learning (ML), Others) By End-User (Hospitals, Homecare setting, Others)&nbsp;and By Region (North America, Europe, South America, Asia Pacific, Middle East, and Africa) &ndash; Share, Size, Outlook, and Opportunity Analysis, 2024-2031</h2>

<h3>Market Overview</h3>

<blockquote>
Global Digital Diabetes Market reached US$ YY&nbsp;million in 2022 and is expected to reach US$ YY&nbsp;million by 2031, growing with a CAGR of YY% during the forecast period 2024-2031.
</blockquote>

Digital Diabetes refers to the integration of digital technologies into the comprehensive management and treatment of diabetes. This evolving field leverages advancements in mobile applications, wearable devices, continuous glucose monitoring systems, artificial intelligence, and telemedicine to enhance the monitoring, understanding, and care of individuals living with diabetes.

The use of artificial intelligence and machine learning in diabetes management is likely to expand. These technologies can analyze vast amounts of data to predict blood sugar trends, optimize treatment plans, and provide personalized recommendations for lifestyle modifications. Enhanced remote monitoring capabilities may lead to improved patient outcomes. This includes real-time data transmission from wearable devices to healthcare providers, allowing for proactive intervention and timely adjustments to treatment plans.

<h3>Market Scope</h3>

<table cellspacing="0" style="border-collapse:collapse">
	<tbody>
		<tr>
			<td style="background-color:#4472c4; border-bottom:1px solid #4472c4; border-left:1px solid #4472c4; border-right:1px solid #8eaadb; border-top:1px solid #4472c4; vertical-align:top; width:312px">
			Metrics
			</td>
			<td style="background-color:#4472c4; border-bottom:1px solid #4472c4; border-left:1px solid #8eaadb; border-right:1px solid #4472c4; border-top:1px solid #4472c4; vertical-align:top; width:312px">
			Details
			</td>
		</tr>
		<tr>
			<td style="background-color:#d9e2f3; border-bottom:1px solid #8eaadb; border-left:1px solid #8eaadb; border-right:1px solid #8eaadb; border-top:1px solid #4472c4; vertical-align:middle; width:312px">
			CAGR
			</td>
			<td style="background-color:#d9e2f3; border-bottom:1px solid #8eaadb; border-left:1px solid #8eaadb; border-right:1px solid #8eaadb; border-top:1px solid #4472c4; vertical-align:middle; width:312px">
			YY%
			</td>
		</tr>
		<tr>
			<td style="background-color:#d6e6f4; border-bottom:1px solid #8eaadb; border-left:1px solid #8eaadb; border-right:1px solid #8eaadb; border-top:1px solid #8eaadb; vertical-align:middle; width:312px">
			Size Available for Years
			</td>
			<td style="background-color:#d6e6f4; border-bottom:1px solid #8eaadb; border-left:1px solid #8eaadb; border-right:1px solid #8eaadb; border-top:1px solid #8eaadb; vertical-align:middle; width:312px">
			2022-2031
			</td>
		</tr>
		<tr>
			<td style="background-color:#d9e2f3; border-bottom:1px solid #8eaadb; border-left:1px solid #8eaadb; border-right:1px solid #8eaadb; border-top:1px solid #8eaadb; vertical-align:middle; width:312px">
			Forecast Period
			</td>
			<td style="background-color:#d9e2f3; border-bottom:1px solid #8eaadb; border-left:1px solid #8eaadb; border-right:1px solid #8eaadb; border-top:1px solid #8eaadb; vertical-align:middle; width:312px">
			2024-2031
			</td>
		</tr>
		<tr>
			<td style="background-color:#d6e6f4; border-bottom:1px solid #8eaadb; border-left:1px solid #8eaadb; border-right:1px solid #8eaadb; border-top:1px solid #8eaadb; vertical-align:middle; width:312px">
			Data Availability
			</td>
			<td style="background-color:#d6e6f4; border-bottom:1px solid #8eaadb; border-left:1px solid #8eaadb; border-right:1px solid #8eaadb; border-top:1px solid #8eaadb; vertical-align:middle; width:312px">
			Value (US$)&nbsp;
			</td>
		</tr>
		<tr>
			<td style="background-color:#d9e2f3; border-bottom:1px solid #8eaadb; border-left:1px solid #8eaadb; border-right:1px solid #8eaadb; border-top:1px solid #8eaadb; vertical-align:middle; width:312px">
			Segments Covered
			</td>
			<td style="background-color:#d9e2f3; border-bottom:1px solid #8eaadb; border-left:1px solid #8eaadb; border-right:1px solid #8eaadb; border-top:1px solid #8eaadb; vertical-align:middle; width:312px">
			Type, Solution, Technology, End-User
			</td>
		</tr>
		<tr>
			<td style="background-color:#d6e6f4; border-bottom:1px solid #8eaadb; border-left:1px solid #8eaadb; border-right:1px solid #8eaadb; border-top:1px solid #8eaadb; vertical-align:middle; width:312px">
			Regions Covered
			</td>
			<td style="background-color:#d6e6f4; border-bottom:1px solid #8eaadb; border-left:1px solid #8eaadb; border-right:1px solid #8eaadb; border-top:1px solid #8eaadb; vertical-align:middle; width:312px">
			North America, Europe, Asia-Pacific, South America and Middle East &amp; Africa
			</td>
		</tr>
		<tr>
			<td style="background-color:#d9e2f3; border-bottom:1px solid #8eaadb; border-left:1px solid #8eaadb; border-right:1px solid #8eaadb; border-top:1px solid #8eaadb; vertical-align:middle; width:312px">
			Largest Growing Region
			</td>
			<td style="background-color:#d9e2f3; border-bottom:1px solid #8eaadb; border-left:1px solid #8eaadb; border-right:1px solid #8eaadb; border-top:1px solid #8eaadb; vertical-align:middle; width:312px">
			North America
			</td>
		</tr>
		<tr>
			<td style="background-color:#d6e6f4; border-bottom:1px solid #8eaadb; border-left:1px solid #8eaadb; border-right:1px solid #8eaadb; border-top:1px solid #8eaadb; vertical-align:middle; width:312px">
			Fastest Region
			</td>
			<td style="background-color:#d6e6f4; border-bottom:1px solid #8eaadb; border-left:1px solid #8eaadb; border-right:1px solid #8eaadb; border-top:1px solid #8eaadb; vertical-align:middle; width:312px">
			Asia-Pacific
			</td>
		</tr>
		<tr>
			<td style="background-color:#d9e2f3; border-bottom:1px solid #8eaadb; border-left:1px solid #8eaadb; border-right:1px solid #8eaadb; border-top:1px solid #8eaadb; vertical-align:middle; width:312px">
			Report Insights Covered
			</td>
			<td style="background-color:#d9e2f3; border-bottom:1px solid #8eaadb; border-left:1px solid #8eaadb; border-right:1px solid #8eaadb; border-top:1px solid #8eaadb; vertical-align:middle; width:312px">
			Competitive Landscape Analysis, Company Profile Analysis, Market Size, Share, Growth, Demand, Recent Developments, Mergers and Acquisitions, New Product Launches, Growth Strategies, Revenue Analysis, Porter&rsquo;s Analysis, Pricing Analysis, Regulatory Analysis, Supply-Chain Analysis and Other key Insights.
			</td>
		</tr>
	</tbody>
</table>

&nbsp;

For more details of the report -&nbsp;<a href="https://www.datamintelligence.com/download-sample/digital-diabetes-market" target="_blank">Request for sample</a>

<h3>&nbsp;</h3>

<h3>Market Dynamics: Drivers and Restraints</h3>

Increasing prevalence of diabetes

The growing number of individuals diagnosed with diabetes expands the potential market size for digital diabetes solutions. As more people require effective tools for managing their condition, there is a greater demand for digital technologies that can offer personalized and efficient diabetes care. Diabetes is a chronic condition that requires continuous monitoring of blood glucose levels, lifestyle factors, and treatment effectiveness. Digital solutions, such as continuous glucose monitoring (CGM) systems and wearable devices, fulfill the need for real-time data, enabling individuals and healthcare providers to make timely and informed decisions.

The diversity in diabetes management needs among individuals emphasizes the importance of personalized treatment plans. Digital technologies, including mobile apps and AI-driven platforms, can analyze patient data to offer tailored insights, treatment recommendations, and lifestyle modifications based on individual health profiles.

For instance, according to World Health Organization, estimated that, about 422 million people worldwide have diabetes, the majority living in low-and middle-income countries, and 1.5 million deaths are directly attributed to diabetes each year. Both the number of cases and the prevalence of diabetes have been steadily increasing over the past few decades.

<h3>Restraint</h3>

Data security and privacy concerns

The healthcare industry is a prime target for cyberattacks due to the wealth of sensitive information it holds. A data breach in a digital diabetes platform could lead to the exposure of personal health data, potentially resulting in identity theft, fraud, or other malicious activities. Stringent data protection regulations, such as the General Data Protection Regulation (GDPR) and the Health Insurance Portability and Accountability Act (HIPAA), impose strict requirements on the handling and storage of health data.&nbsp;

Ensuring compliance with these regulations can be challenging for digital health companies, leading to legal and regulatory hurdles. Individuals with diabetes may fear that the disclosure of their health information could lead to stigmatization or discrimination in various aspects of life, including employment, insurance coverage, or social interactions. Such concerns can discourage people from actively using digital diabetes tools.&nbsp;

Individuals may feel that they have insufficient control over how their health data is collected, stored, and used within digital diabetes solutions. A perceived lack of control can lead to anxiety and hesitation in adopting these technologies.

<h3>Segment Analysis</h3>

The global digital diabetes market is segmented based on type, solution, technology, end-user and region.

The insulin delivery devices segment from the solution segment accounted for approximately 44.19% of share

The rise of insulin delivery devices has been driven by several factors that aim to improve the administration of insulin for individuals with diabetes. These devices are designed to provide more convenient, accurate, and personalized insulin delivery, addressing some of the challenges associated with traditional insulin administration methods.

Insulin delivery devices, such as insulin pens and insulin pumps, offer enhanced convenience compared to traditional vial and syringe methods. They are often more portable, discrete, and user-friendly, allowing individuals to administer insulin more easily and discreetly in various settings. Many insulin delivery devices are designed to be user-friendly, reducing the complexity associated with traditional methods. This is particularly beneficial for individuals who may have difficulty with manual dexterity or those who are new to insulin therapy.

Additionally, the rise of prduct launches helps to boost the segment growth. For instance, in February 2024, Tandem Diabetes Care, an American company specialising in insulin delivery and diabetes technology, had launched Tandem Mobi, in the US. Tandem Mobi is a compact and robust automated insulin delivery system designed for individuals with diabetes. Moreover, in November 2023, ViCentra had launched a hybrid closed-loop automated insulin delivery system that uses the Dexcom G6 CGM. Utrecht, The Netherlands-based ViCentra designed the system to deliver insulin through its Kaleido insulin pump.

<h3>Geographical Analysis</h3>

North America accounted for approximately 33.11% of the market share in 2022

Some of the factors that are driving the market growth in the North American region include increasing prevalence of diabetes, rising adoption of CGM devices, technological advancements, and the presence of key companies are some of the factors contributing to the market growth. Additionally, the efforts taken by the federal government to manage the disease at a larger level is fueling the market growth.

For instance, according to the National Diabetes Statistics Report 2022 by the CDC, over 130 million adults in the United States are either suffering from diabetes or have prediabetes. The high per capita income and increasing healthcare spending are among the key factors likely to drive market growth.&nbsp;

The American Diabetes Association released the Economic Costs of Diabetes in the U.S. report in November 2023, highlighting the economic impact of diabetes in 2022. According to the report, the total cost of diabetes in 2022 was $412.9 billion, including $306.6 billion in direct medical costs and $106.3 billion in indirect costs.&nbsp;

Key players in the U.S. are executing various strategies to expand their market share. For instance, on February 08, 2023, DarioHealth Corp, a leader in the global digital therapeutics (DTx) market, had partnered with Dexcom, the global leader in real-time continuous glucose monitoring (CGM) technology, to integrate its market-leading CGMs, into Dario&#39;s multi-chronic condition platform.

<h3>COVID-19 Impact Analysis</h3>

The pandemic led to disruptions in global supply chains, affecting the production and distribution of medical devices, including CGM devices. Delays in the manufacturing and transportation of components or finished products could have impacted the availability of CGM devices in certain regions.

The strain on healthcare resources and priorities during the pandemic may have diverted attention and resources away from non-essential medical services. This could have affected the promotion, adoption, and routine use of CGM devices as healthcare systems focused on managing COVID-19 cases. Patients&#39; priorities may have shifted during the pandemic, with a focus on immediate health concerns related to COVID-19. This shift in priorities could have influenced the decision-making process regarding the adoption and utilization of CGM devices for diabetes management.

<h3>Competitive Landscape</h3>

The major global players in the market include Dexcom, Medtronic Plc, Abbott Laboratories, Roche Diabetes Care, Teladoc Health, Welldoc, Virtal Health, Insulet Corporation, Beta Bionics, Dario among others.

<h3>Key Developments</h3>

<ul>
	<li>In June 2023, Know Labs launched a generation 1 device that uses the company&rsquo;s Bio-RFID technology to measure blood glucose through the skin using radio waves and machine-learning algorithms. The Know Labs&rsquo;s device feasibility trial compared its BioRFID sensor technology to Dexcom&rsquo;s G6 device.</li>
	<li>In December 2023, Tandem Diabetes Care (Nasdaq:TNDM) announced today that it launched Tandem Source, a diabetes management platform. The platform, for both insulin pump users and healthcare providers, brings together features of Tandem Diabetes Care&rsquo;s legacy offerings. It combines t:connect HCP and t:connect Portal with new, comprehensive data reporting in one central, scalable platform.</li>
</ul>

<h3>Why Purchase the Report?</h3>

<ul>
	<li>To visualize the global digital diabetes market segmentation based on type, solution, technology, end-user and region as well as understand key commercial assets and players.</li>
	<li>Identify commercial opportunities by analyzing trends and co-development.&nbsp;</li>
	<li>Excel data sheet with numerous data points of digital diabetes market-level with all segments.</li>
	<li>PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.</li>
	<li>Product mapping available as excel consisting of key products of all the major players.</li>
</ul>

The global digital diabetes market report would provide approximately 69 tables, 69 figures and 187 Pages.

<h3>Target Audience 2024</h3>

<ul>
	<li>Manufacturers/ Buyers</li>
	<li>Industry Investors/Investment Bankers</li>
	<li>Research Professionals</li>
	<li>Emerging Companies</li>
</ul>

<ol>
	<li>
	<h3 style="color:#1f3863; font-style:normal">Methodology and Scope</h3>

	<ol>
		<li>Research Methodology</li>
		<li>Research Objective and Scope of the Report</li>
	</ol>
	</li>
	<li>
	<h3 style="color:#1f3863; font-style:normal">Definition and Overview</h3>
	</li>
	<li>
	<h3 style="color:#1f3863; font-style:normal">Executive Summary</h3>

	<ol>
		<li>Snippet by Type</li>
		<li>Snippet by Solution</li>
		<li>Snippet by Technology</li>
		<li>Snippet by End-User</li>
		<li>Snippet by Region</li>
	</ol>
	</li>
	<li>
	<h3 style="color:#1f3863; font-style:normal">Market Dynamics</h3>

	<ol>
		<li>Impacting Factors
		<ol>
			<li>Drivers
			<ol>
				<li>Increasing prevalence of diabetes</li>
				<li>The rise of remote patient monitoring&nbsp;</li>
			</ol>
			</li>
		</ol>
		</li>
		<li>Restraints
		<ol>
			<li>Data security and privacy concerns</li>
		</ol>

		<ol>
			<li>Opportunity</li>
			<li>Impact Analysis</li>
		</ol>
		</li>
	</ol>
	</li>
	<li>
	<h3 style="color:#1f3863; font-style:normal">Industry Analysis&nbsp;</h3>

	<ol>
		<li>Porter&#39;s Five Force Analysis&nbsp;</li>
		<li>Supply Chain Analysis</li>
		<li>Pricing Analysis</li>
		<li>Regulatory Analysis</li>
		<li>Unmet Needs</li>
		<li>DMI Opinion</li>
	</ol>
	</li>
	<li>
	<h3 style="color:#1f3863; font-style:normal">COVID-19 Analysis</h3>

	<ol>
		<li>Analysis of COVID-19
		<ol>
			<li>Scenario Before COVID</li>
			<li>Scenario During COVID</li>
			<li>Scenario Post COVID</li>
		</ol>
		</li>
		<li>Pricing Dynamics Amid COVID-19</li>
		<li>Demand-Supply Spectrum</li>
		<li>Government Initiatives Related to the Market During Pandemic</li>
		<li>Manufacturers Strategic Initiatives</li>
		<li>Conclusion</li>
	</ol>
	</li>
	<li>
	<h3 style="color:#1f3863; font-style:normal">By Type</h3>

	<ol>
		<li>Introduction
		<ol>
			<li>Market Size Analysis and Y-o-Y Growth Analysis (%), By Type</li>
			<li>Market Attractiveness Index, By Type</li>
		</ol>
		</li>
		<li>Type 1 Diabetes *
		<ol>
			<li>Introduction</li>
			<li>Market Size Analysis and Y-o-Y Growth Analysis (%)</li>
		</ol>
		</li>
		<li>Type 2 Diabetes</li>
	</ol>
	</li>
	<li>
	<h3 style="color:#1f3863; font-style:normal">By Solution</h3>

	<ol>
		<li>Introduction
		<ol>
			<li>Market Size Analysis and Y-o-Y Growth Analysis (%), By Solution</li>
			<li>Market Attractiveness Index, By Solution</li>
		</ol>
		</li>
		<li>Glucose Monitoring Systems *
		<ol>
			<li>Introduction</li>
			<li>Market Size Analysis and Y-o-Y Growth Analysis (%)</li>
		</ol>
		</li>
		<li>Insulin Delivery Devices</li>
		<li>Diabetes Management Apps</li>
		<li>Telemedicine Services</li>
		<li>Others</li>
	</ol>
	</li>
	<li>
	<h3 style="color:#1f3863; font-style:normal">By Technology</h3>

	<ol>
		<li>Introduction
		<ol>
			<li>Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology</li>
			<li>Market Attractiveness Index, By Technology</li>
		</ol>
		</li>
		<li>IoT and Wearables *
		<ol>
			<li>Introduction</li>
			<li>Market Size Analysis and Y-o-Y Growth Analysis (%)</li>
		</ol>
		</li>
		<li>Mobile Applications</li>
		<li>Web-based Solutions</li>
		<li>Artificial Intelligence (AI) and Machine Learning (ML)</li>
		<li>Others</li>
	</ol>
	</li>
	<li>
	<h3 style="color:#1f3863; font-style:normal">By End-User</h3>

	<ol>
		<li>Introduction
		<ol>
			<li>Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User</li>
			<li>Market Attractiveness Index, By End-User</li>
		</ol>
		</li>
		<li>Hospitals *
		<ol>
			<li>Introduction</li>
			<li>Market Size Analysis and Y-o-Y Growth Analysis (%)</li>
		</ol>
		</li>
		<li>Homecare setting</li>
		<li>Others</li>
	</ol>
	</li>
	<li>
	<h3 style="color:#1f3863; font-style:normal">By Region</h3>

	<ol>
		<li>Introduction
		<ol>
			<li>Market Size Analysis and Y-o-Y Growth Analysis (%), By Region</li>
			<li>Market Attractiveness Index, By Region</li>
		</ol>
		</li>
		<li>North America
		<ol>
			<li>Introduction</li>
			<li>Key Region-Specific Dynamics</li>
			<li>Market Size Analysis and Y-o-Y Growth Analysis (%), By Type</li>
			<li>Market Size Analysis and Y-o-Y Growth Analysis (%), By Solution</li>
			<li>Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology</li>
			<li>Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User</li>
			<li>Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
			<ol>
				<li>U.S.</li>
				<li>Canada</li>
				<li>Mexico</li>
			</ol>
			</li>
		</ol>
		</li>
		<li>Europe
		<ol>
			<li>Introduction</li>
			<li>Key Region-Specific Dynamics</li>
			<li>Market Size Analysis and Y-o-Y Growth Analysis (%), By Type</li>
			<li>Market Size Analysis and Y-o-Y Growth Analysis (%), By Solution</li>
			<li>Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology</li>
			<li>Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User</li>
			<li>Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
			<ol>
				<li>Germany</li>
				<li>UK</li>
				<li>France</li>
				<li>Italy</li>
				<li>Spain</li>
				<li>Rest of Europe</li>
			</ol>
			</li>
		</ol>
		</li>
		<li>South America
		<ol>
			<li>Introduction</li>
			<li>Key Region-Specific Dynamics</li>
			<li>Market Size Analysis and Y-o-Y Growth Analysis (%), By Type</li>
			<li>Market Size Analysis and Y-o-Y Growth Analysis (%), By Solution</li>
			<li>Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology</li>
			<li>Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User</li>
			<li>Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
			<ol>
				<li>Brazil</li>
				<li>Argentina</li>
				<li>Rest of South America</li>
			</ol>
			</li>
		</ol>
		</li>
		<li>Asia-Pacific
		<ol>
			<li>Introduction</li>
			<li>Key Region-Specific Dynamics</li>
			<li>Market Size Analysis and Y-o-Y Growth Analysis (%), By Type</li>
			<li>Market Size Analysis and Y-o-Y Growth Analysis (%), By Solution</li>
			<li>Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology</li>
			<li>Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User</li>
			<li>Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
			<ol>
				<li>China</li>
				<li>India</li>
				<li>Japan</li>
				<li>South Korea</li>
				<li>Rest of Asia-Pacific</li>
			</ol>
			</li>
		</ol>
		</li>
		<li>Middle East and Africa
		<ol>
			<li>Introduction</li>
			<li>Key Region-Specific Dynamics</li>
			<li>Market Size Analysis and Y-o-Y Growth Analysis (%), By Type</li>
			<li>Market Size Analysis and Y-o-Y Growth Analysis (%), By Solution</li>
			<li>Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology</li>
			<li>Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User</li>
		</ol>
		</li>
	</ol>
	</li>
	<li>
	<h3 style="color:#1f3863; font-style:normal">Competitive Landscape</h3>

	<ol>
		<li>Competitive Scenario</li>
		<li>Market Positioning/Share Analysis</li>
		<li>Mergers and Acquisitions Analysis</li>
	</ol>
	</li>
	<li>
	<h3 style="color:#1f3863; font-style:normal">Company Profiles</h3>

	<ol>
		<li>Dexcom *
		<ol>
			<li>Company Overview</li>
			<li>Product Portfolio and Description</li>
			<li>Financial Overview</li>
			<li>Key Developments</li>
		</ol>
		</li>
		<li>Medtronic Plc</li>
		<li>Abbott Laboratories</li>
		<li>Roche Diabetes Care</li>
		<li>Teladoc Health</li>
		<li>Welldoc</li>
		<li>Virtal Health</li>
		<li>Insulet Corporation</li>
		<li>Beta Bionics</li>
		<li>Dario&nbsp;(LIST NOT EXHAUSTIVE)&nbsp;</li>
	</ol>
	</li>
	<li>
	<h3 style="color:#1f3863; font-style:normal">Appendix</h3>

	<ol>
		<li>About Us and Services</li>
		<li>Contact Us</li>
	</ol>
	</li>
</ol>

List of Tables

Table 1 Global Digital Diabetes Market Value, By Type, 2023, 2027 &amp; 2031 (US$ Million)

Table 2 Global Digital Diabetes Market Value, By Solution, 2023, 2027 &amp; 2031 (US$ Million)

Table 3 Global Digital Diabetes Market Value, By Technology, 2023, 2027 &amp; 2031 (US$ Million)

Table 4 Global Digital Diabetes Market Value, By End-User, 2023, 2027 &amp; 2031 (US$ Million)

Table 5 Global Digital Diabetes Market Value, By Region, 2023, 2027 &amp; 2031 (US$ Million)

Table 6 Global Digital Diabetes Market Value, By Type, 2023, 2027 &amp; 2031 (US$ Million)

Table 7 Global Digital Diabetes Market Value, By Type, 2022-2031 (US$ Million)

Table 8 Global Digital Diabetes Market Value, By Solution, 2023, 2027 &amp; 2031 (US$ Million)

Table 9 Global Digital Diabetes Market Value, By Solution, 2022-2031 (US$ Million)

Table 10 Global Digital Diabetes Market Value, By Technology, 2023, 2027 &amp; 2031 (US$ Million)

Table 11 Global Digital Diabetes Market Value, By Technology, 2022-2031 (US$ Million)

Table 12 Global Digital Diabetes Market Value, By End-User, 2023, 2027 &amp; 2031 (US$ Million)

Table 13 Global Digital Diabetes Market Value, By End-User, 2022-2031 (US$ Million)

Table 14 Global Digital Diabetes Market Value, By Region, 2023, 2027 &amp; 2031 (US$ Million)

Table 15 Global Digital Diabetes Market Value, By Region, 2022-2031 (US$ Million)

Table 16 North America Digital Diabetes Market Value, By Type, 2022-2031 (US$ Million)

Table 17 North America Digital Diabetes Market Value, By Solution, 2022-2031 (US$ Million)

Table 18 North America Digital Diabetes Market Value, By Technology, 2022-2031 (US$ Million)

Table 19 North America Digital Diabetes Market Value, By End-User, 2022-2031 (US$ Million)

Table 20 North America Digital Diabetes Market Value, By Country, 2022-2031 (US$ Million)

Table 21 South America Digital Diabetes Market Value, By Type, 2022-2031 (US$ Million)

Table 22 South America Digital Diabetes Market Value, By Solution, 2022-2031 (US$ Million)

Table 23 South America Digital Diabetes Market Value, By Technology, 2022-2031 (US$ Million)

Table 24 South America Digital Diabetes Market Value, By End-User, 2022-2031 (US$ Million)

Table 25 South America Digital Diabetes Market Value, By Country, 2022-2031 (US$ Million)

Table 26 Europe Digital Diabetes Market Value, By Type, 2022-2031 (US$ Million)

Table 27 Europe Digital Diabetes Market Value, By Solution, 2022-2031 (US$ Million)

Table 28 Europe Digital Diabetes Market Value, By Technology, 2022-2031 (US$ Million)

Table 29 Europe Digital Diabetes Market Value, By End-User, 2022-2031 (US$ Million)

Table 30 Europe Digital Diabetes Market Value, By Country, 2022-2031 (US$ Million)

Table 31 Asia-Pacific Digital Diabetes Market Value, By Type, 2022-2031 (US$ Million)

Table 32 Asia-Pacific Digital Diabetes Market Value, By Solution, 2022-2031 (US$ Million)

Table 33 Asia-Pacific Digital Diabetes Market Value, By Technology, 2022-2031 (US$ Million)

Table 34 Asia-Pacific Digital Diabetes Market Value, By End-User, 2022-2031 (US$ Million)

Table 35 Asia-Pacific Digital Diabetes Market Value, By Country, 2022-2031 (US$ Million)

Table 36 Middle East &amp; Africa Digital Diabetes Market Value, By Type, 2022-2031 (US$ Million)

Table 37 Middle East &amp; Africa Digital Diabetes Market Value, By Solution, 2022-2031 (US$ Million)

Table 38 Middle East &amp; Africa Digital Diabetes Market Value, By Technology, 2022-2031 (US$ Million)

Table 39 Middle East &amp; Africa Digital Diabetes Market Value, By End-User, 2022-2031 (US$ Million)

Table 40 Dexcom: Overview

Table 41 Dexcom: Product Portfolio

Table 42 Dexcom: Key Developments

Table 43 Medtronic Plc: Overview

Table 44 Medtronic Plc: Product Portfolio

Table 45 Medtronic Plc: Key Developments

Table 46 Abbott Laboratories: Overview

Table 47 Abbott Laboratories: Product Portfolio

Table 48 Abbott Laboratories: Key Developments

Table 49 Roche Diabetes Care: Overview

Table 50 Roche Diabetes Care: Product Portfolio

Table 51 Roche Diabetes Care: Key Developments

Table 52 Teladoc Health: Overview

Table 53 Teladoc Health: Product Portfolio

Table 54 Teladoc Health: Key Developments

Table 55 Welldoc: Overview

Table 56 Welldoc: Product Portfolio

Table 57 Welldoc: Key Developments

Table 58 Virtal Health: Overview

Table 59 Virtal Health: Product Portfolio

Table 60 Virtal Health: Key Developments

Table 61 Insulet Corporation: Overview

Table 62 Insulet Corporation: Product Portfolio

Table 63 Insulet Corporation: Key Developments

Table 64 Beta Bionics: Overview

Table 65 Beta Bionics: Product Portfolio

Table 66 Beta Bionics: Key Developments

Table 67 Dario: Overview

Table 68 Dario: Product Portfolio

Table 69 Dario: Key Developments

List of Figures

Figure 1 Global Digital Diabetes Market Value, 2022-2031 (US$ Million)

Figure 2 Global Digital Diabetes Market Share, By Type, 2022 &amp; 2030 (%)

Figure 3 Global Digital Diabetes Market Share, By Solution, 2022 &amp; 2030 (%)

Figure 4 Global Digital Diabetes Market Share, By Technology, 2022 &amp; 2030 (%)

Figure 5 Global Digital Diabetes Market Share, By End-User, 2022 &amp; 2030 (%)

Figure 6 Global Digital Diabetes Market Share, By Region, 2022 &amp; 2030 (%)

Figure 7 Global Digital Diabetes Market Y-o-Y Growth, By Type, 2022-2030 (%)

Figure 8 Type 1 Diabetes Digital Diabetes Market Value, 2022-2031 (US$ Million)

Figure 9 Type 2 Diabetes Digital Diabetes Market Value, 2022-2031 (US$ Million)

Figure 10 Global Digital Diabetes Market Y-o-Y Growth, By Solution, 2022-2030 (%)

Figure 11 Glucose Monitoring Systems Solution in Global Digital Diabetes Market Value, 2022-2031 (US$ Million)

Figure 12 Insulin Delivery Devices Solution in Global Digital Diabetes Market Value, 2022-2031 (US$ Million)

Figure 13 Diabetes Management Apps Solution in Global Digital Diabetes Market Value, 2022-2031 (US$ Million)

Figure 14 Telemedicine Services Solution in Global Digital Diabetes Market Value, 2022-2031 (US$ Million)

Figure 15 Others Solution in Global Digital Diabetes Market Value, 2022-2031 (US$ Million)

Figure 16 Global Digital Diabetes Market Y-o-Y Growth, By Technology, 2022-2030 (%)

Figure 17 IoT and Wearables Technology in Global Digital Diabetes Market Value, 2022-2031 (US$ Million)

Figure 18 Mobile Applications Technology in Global Digital Diabetes Market Value, 2022-2031 (US$ Million)

Figure 19 Web-based Solutions Technology in Global Digital Diabetes Market Value, 2022-2031 (US$ Million)

Figure 20 Artificial Intelligence (AI) and Machine Learning (ML) Technology in Global Digital Diabetes Market Value, 2022-2031 (US$ Million)

Figure 21 Global Digital Diabetes Market Y-o-Y Growth, By End-User, 2022-2030 (%)

Figure 22 Hospitals End-User in Global Digital Diabetes Market Value, 2022-2031 (US$ Million)

Figure 23 Homecare setting End-User in Global Digital Diabetes Market Value, 2022-2031 (US$ Million)

Figure 24 Others End-User in Global Digital Diabetes Market Value, 2022-2031 (US$ Million)

Figure 25 Global Digital Diabetes Market Y-o-Y Growth, By Region, 2022-2030 (%)

Figure 26 North America Digital Diabetes Market Value, 2022-2031 (US$ Million)

Figure 27 Asia-Pacific Digital Diabetes Market Value, 2022-2031 (US$ Million)

Figure 28 Europe Digital Diabetes Market Value, 2022-2031 (US$ Million)

Figure 29 South America Digital Diabetes Market Value, 2022-2031 (US$ Million)

Figure 30 Middle East and Africa Digital Diabetes Market Value, 2022-2031 (US$ Million)

Figure 31 North America Digital Diabetes Market Value, 2022-2031 (US$ Million)

Figure 32 North America Digital Diabetes Market Share, By Type, 2022 &amp; 2030 (%)

Figure 33 North America Digital Diabetes Market Share, By Solution, 2022 &amp; 2030 (%)

Figure 34 North America Digital Diabetes Market Share, By Technology, 2022 &amp; 2030 (%)

Figure 35 North America Digital Diabetes Market Share, By End-User, 2022 &amp; 2030 (%)

Figure 36 North America Digital Diabetes Market Share, By Country, 2022 &amp; 2030 (%)

Figure 37 South America Digital Diabetes Market Value, 2022-2031 (US$ Million)

Figure 38 South America Digital Diabetes Market Share, By Type, 2022 &amp; 2030 (%)

Figure 39 South America Digital Diabetes Market Share, By Solution, 2022 &amp; 2030 (%)

Figure 40 South America Digital Diabetes Market Share, By Technology, 2022 &amp; 2030 (%)

Figure 41 South America Digital Diabetes Market Share, By End-User, 2022 &amp; 2030 (%)

Figure 42 South America Digital Diabetes Market Share, By Country, 2022 &amp; 2030 (%)

Figure 43 Europe Digital Diabetes Market Value, 2022-2031 (US$ Million)

Figure 44 Europe Digital Diabetes Market Share, By Type, 2022 &amp; 2030 (%)

Figure 45 Europe Digital Diabetes Market Share, By Solution, 2022 &amp; 2030 (%)

Figure 46 Europe Digital Diabetes Market Share, By Technology, 2022 &amp; 2030 (%)

Figure 47 Europe Digital Diabetes Market Share, By End-User, 2022 &amp; 2030 (%)

Figure 48 Europe Digital Diabetes Market Share, By Country, 2022 &amp; 2030 (%)

Figure 49 Asia-Pacific Digital Diabetes Market Value, 2022-2031 (US$ Million)

Figure 50 Asia-Pacific Digital Diabetes Market Share, By Type, 2022 &amp; 2030 (%)

Figure 51 Asia-Pacific Digital Diabetes Market Share, By Solution, 2022 &amp; 2030 (%)

Figure 52 Asia-Pacific Digital Diabetes Market Share, By Technology, 2022 &amp; 2030 (%)

Figure 53 Asia-Pacific Digital Diabetes Market Share, By End-User, 2022 &amp; 2030 (%)

Figure 54 Asia-Pacific Digital Diabetes Market Share, By Country, 2022 &amp; 2030 (%)

Figure 55 Middle East &amp; Africa Digital Diabetes Market Value, 2022-2031 (US$ Million)

Figure 56 Middle East &amp; Africa Digital Diabetes Market Share, By Type, 2022 &amp; 2030 (%)

Figure 57 Middle East &amp; Africa Digital Diabetes Market Share, By Solution, 2022 &amp; 2030 (%)

Figure 58 Middle East &amp; Africa Digital Diabetes Market Share, By Technology, 2022 &amp; 2030 (%)

Figure 59 Middle East &amp; Africa Digital Diabetes Market Share, By End-User, 2022 &amp; 2030 (%)

Figure 60 Dexcom: Financials

Figure 61 Medtronic Plc: Financials

Figure 62 Abbott Laboratories: Financials

Figure 63 Roche Diabetes Care: Financials

Figure 64 Teladoc Health: Financials

Figure 65 Welldoc: Financials

Figure 66 Virtal Health: Financials

Figure 67 Insulet Corporation: Financials

Figure 68 Beta Bionics: Financials

Figure 69 Dario: Financials

Digital Diabetes Market Size, Share, Industry, Forecast and outlook (2024-2031)

Artificial Intelligence (AI) Robots Market Size, Share and Outlook (2024-2031)

Published: 2024 April 19

Starting from

Digital Diabetes Management Market Outlook, Opportunities, Demand, Competitive Analysis and Market Forecast 2023-2030

Published: 2023 September 08

Starting from

Digital Health Market Size, Share, Industry, Forecast and outlook (2023-2030)

Published: 2023 November 24

Starting from